Drug Shortage Report for ESBRIET
| Report ID | 137715 |
| Drug Identification Number | 02464489 |
| Brand name | ESBRIET |
| Common or Proper name | ESBRIET 267MG 270 |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PIRFENIDONE |
| Strength(s) | 267MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 270 |
| ATC code | L04AX |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2021-05-10 |
| Actual start date | 2021-05-10 |
| Estimated end date | 2021-06-07 |
| Actual end date | 2021-05-31 |
| Shortage status | Resolved |
| Updated date | 2021-06-01 |
| Company comments | 267 mg capsules or 801mg tablets (where appropriate) are an alternative and not impacted by shortage |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2021-06-01 | English | Compare |
| v11 | 2021-05-31 | French | Compare |
| v10 | 2021-05-31 | English | Compare |
| v9 | 2021-05-11 | English | Compare |
| v8 | 2021-04-27 | French | Compare |
| v7 | 2021-04-27 | English | Compare |
| v6 | 2021-04-26 | English | Compare |
| v5 | 2021-04-20 | French | Compare |
| v4 | 2021-04-20 | English | Compare |
| v3 | 2021-04-20 | English | Compare |
| v2 | 2021-04-20 | French | Compare |
| v1 | 2021-04-20 | English | Compare |
Showing 1 to 12 of 12